Panel Discussion

Monday, March 9, 2026

8:42 AM - 9:00 AM EST

Location: Cabinet

Moderator(s)

Mona Advani, M.Sc., MBA

Principal Regulatory Consultant
CardioMed Device Consultants
HERNDON, Virginia, United States

Disclosure(s): No financial relationships to disclose
Rafael Beyar, MD, DSc, MPH

Interventional cardiologists and President
Rambam Hospital/ Rambam Friends Organizations
Haifa, Israel

Disclosure(s): ALIVE VC: Managing General Partner (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Director and stock owner (Ongoing); Cuspa medical: Advisor (Ongoing), Stock Options [in privately held companies] (Ongoing); medhub AI: Stock-privately held company (Ongoing)

Panel Discussant(s)

Rocco Armonda, MD

Director, Neuroendovascular Surgery
Washington Hospital Center
Silver Spring, Maryland, United States

Disclosure(s): No financial relationships to disclose
Yiannis S. Chatzizisis, MD, PhD

Professor and Chief, Division of Cardiovascular Medicine
University of Miami
Miami, Florida, United States

Disclosure(s): Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Deepakraj Gajanana, MD

Interventional Cardiologist
Cleveland Clinic
Akron , Ohio, United States

Disclosure(s): No financial relationships to disclose
Semih Oktay, PhD

President
Cardiomed Device Consultants
Annapolis, Maryland, United States

Disclosure(s): Medical Device Manufacturers: I am a regulatory consultant to many cardiovascular device manufacturers (Ongoing)
Jonathan Schwartz, MD

Enterprise Director of Cardiovascular Innovation, Structural Interventional Cardiologist
Sanger Heart & Vascular Institute, North Carolina, United States

Disclosure information not submitted.
KT

Kamala Tamirisa, MD

Houston Methodist

Disclosure information not submitted.

Disclosure(s):

Mona Advani, M.Sc., MBA: No financial relationships to disclose

Rafael Beyar, MD, DSc, MPH: ALIVE VC: Managing General Partner (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Director and stock owner (Ongoing); Cuspa medical: Advisor (Ongoing), Stock Options [in privately held companies] (Ongoing); medhub AI: Stock-privately held company (Ongoing)

Rocco Armonda, MD: No financial relationships to disclose

Yiannis S. Chatzizisis, MD, PhD: Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Deepakraj Gajanana, MD: No financial relationships to disclose

Semih Oktay, PhD: Medical Device Manufacturers: I am a regulatory consultant to many cardiovascular device manufacturers (Ongoing)